BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9644783)

  • 1. Prognostic significance of p53 protein overexpression in transitional cell carcinoma of the renal pelvis and ureter.
    Jinza S; Takano Y; Iki M; Noguchi S; Masuda M
    Urol Int; 1998; 60(3):147-51. PubMed ID: 9644783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival.
    Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
    Cancer; 1997 Jun; 79(11):2178-85. PubMed ID: 9179065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter.
    Hashimoto H; Sue Y; Saga Y; Tokumitsu M; Yachiku S
    Int J Urol; 2000 Dec; 7(12):457-63. PubMed ID: 11168685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
    Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
    Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibitor p27(Kip1) expression in transitional cell carcinoma of renal pelvis and ureter.
    Masuda M; Takano Y; Iki M; Makiyama K; Ikeda I; Noguchi S; Hasegawa Y; Hosaka M
    Cancer Lett; 2000 Mar; 150(2):183-9. PubMed ID: 10704741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of p53 and c-erb-2 in transitional cell carcinoma of the kidney pelvis and ureter and its relation to tumor progression and survival].
    Fontana LO; García García F; Arcas Martínez Salas I; García Ligero J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Canteras Jordana M
    Arch Esp Urol; 2002 Sep; 55(7):792-6. PubMed ID: 12380307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions.
    Furihata M; Yamasaki I; Ohtsuki Y; Sonobe H; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
    Int J Cancer; 1995 Oct; 64(5):298-303. PubMed ID: 7591300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
    Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
    Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis.
    García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI
    Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas].
    Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA
    Urologiia; 2004; (3):10-4. PubMed ID: 15199806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunohistochemical factors that predict the synchronous or metachronous development of bladder tumors in patients with upper urinary tract tumors.
    Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee GK; Lee KH
    Urol Int; 2008; 81(3):306-11. PubMed ID: 18931548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.
    Gao JP; Uchida T; Wang C; Jiang SX; Matsumoto K; Satoh T; Minei S; Soh S; Kameya T; Baba S
    Int J Oncol; 2000 Mar; 16(3):469-75. PubMed ID: 10675477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.
    Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M
    J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
    Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
    Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systematic review about the usefulness and prognostic value of the p53 oncoprotein and proliferation marker Ki-67 for upper urinary tract transitional cell carcinoma].
    Moreno Sierra J; Fernández Pérez C; Mazuecos López MP; López García J; Barreales Tolosa L; Fernández Montarroso L; López Corral JC; Blanco Jiménez E; Silmi Moyano A
    Arch Esp Urol; 2004 Apr; 57(3):327-35. PubMed ID: 15174511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.